Alkhaleej Super Speciality Hospital Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 19-12-2024
- Paid Up Capital ₹ 0.10 M
as on 19-12-2024
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2020
- Revenue %
(FY 2020)
- Profit -286.38%
(FY 2020)
- Ebitda -130.03%
(FY 2020)
- Net Worth -55.84%
(FY 2020)
- Total Assets -27.00%
(FY 2020)
About Alkhaleej Super Speciality Hospital
The Corporate was formerly known as Mother Super Speciality Dental Clinic Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Asaf Nechikkadan, Palanpadiyan Anoos, Shameem Nedumkulathil, and One other member serve as directors at the Company.
- CIN/LLPIN
U85120KL2012PTC031913
- Company No.
031913
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Aug 2012
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Palakkad, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Alkhaleej Super Speciality Hospital?
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shameem Nedumkulathil | Director | 14-May-2019 | Current |
Asaf Nechikkadan | Additional Director | 02-Dec-2019 | Current |
Palanpadiyan Anoos | Director | 14-May-2019 | Current |
Anas Kunderi | Director | 24-May-2019 | Current |
Financial Performance of Alkhaleej Super Speciality Hospital.
Alkhaleej Super Speciality Hospital Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 286.38% decrease in profit. The company's net worth observed a substantial decline by a decrease of 55.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Alkhaleej Super Speciality Hospital?
In 2018, Alkhaleej Super Speciality Hospital had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Alkhaleej Super Speciality Hospital?
Unlock and access historical data on people associated with Alkhaleej Super Speciality Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alkhaleej Super Speciality Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alkhaleej Super Speciality Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.